The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I/II study of pazopanib and temozolomide in patients with newly diagnosed and resected glioblastoma: PAZOGLIO trial.
 
Esma Saada-Bouzid
No Relationships to Disclose
 
Jean-Sebastien Frenel
Consulting or Advisory Role - Amgen; AstraZeneca (Inst); Clovis Oncology (Inst); Daiichi Sankyo Europe GmbH (Inst); Eisai; Exact Sciences (Inst); Gilead Sciences; GlaxoSmithKline; Lilly; MSD Oncology (Inst); Novartis (Inst); Pfizer; Seagen
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Europe GmbH; Gilead Sciences; Lilly; MSD Oncology; Novartis; Pfizer; seagen
 
Paule Augereau
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo (Inst); Clovis Oncology (Inst); GlaxoSmithKline (Inst); Novartis/Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca/Daiichi Sankyo; GlaxoSmithKline; Novartis/Pfizer
 
Veronique Bourg
No Relationships to Disclose
 
Jocelyn Gal
No Relationships to Disclose
 
Frédérique Jacquinot
No Relationships to Disclose
 
Carole Gourmelon
No Relationships to Disclose
 
Yann Chateau
No Relationships to Disclose
 
Jerome Barriere
No Relationships to Disclose
 
Pierre-Yves Bondiau
No Relationships to Disclose